MedTrace Logo

Optimizing the Safety of Inter-Hospital Transfer

NCT05876429 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1658

Last updated 2026-01-23

No results posted yet for this study

Summary

This proposal aims to design, implement and rigorously evaluate a standardized accept note in a population of patients that have high frequency of IHT, including patients transferred to the general medical (GMS), cardiology and oncology services at a large tertiary care hospital. This study will improve scientific knowledge by quantifying the patient safety impact of an intervention to improve communication of essential clinical information during IHT. If shown effective, the results of this study can be used to improve clinical practice by establishing evidence-based communication guidelines for broad dissemination. We will also establish technical feasibility by successfully implementing this tool within our EHR (Epic, Verona, WI), allowing for feasible adoption and dissemination to other institutions with similar EHR capabilities. Lastly, we will address malpractice risk by investigating a strategic intervention aimed at reducing known contributors to patient harm during IHT, a high-risk transition in care that involves transfer of high-acuity patients between providers, settings and systems of care.

Conditions

  • Inpatient Facililty Diagnoses

Interventions

OTHER

New Standardized Accept Note

A standardized accept note for transfer patients will be implemented, after stakeholder engagement and subsequent finalization.

OTHER

Existing Transfer Patient Admission Process

Maintain existing transfer patient admission processes, across GMS, Cardiology, and Oncology services.

Sponsors & Collaborators

  • Crico

    collaborator OTHER

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Stephanie Mueller, M.D., M.P.H. · Brigham and Women's Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-17
Primary Completion
2022-07-15
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05876429 on ClinicalTrials.gov